BIRC5 and breast carcinoma: Furthermore, PTPRT was negatively correlated with BIRC5 in other cancer types such as breast carcinoma (BRCA, R = -0.497, P < 0.0001; Fig. 4G), pancreatic adenocarcinoma (PAAD, R = -0.371, P < 0.0001; Fig. 4G), stomach adenocarcinoma (STAD, R = -0.279, P < 0.0001; Fig. 4G), and mesothelioma (MESO, R = -0.465, P < 0.001; Fig. 4G).